Edgestream Partners L.P. Purchases 9,311 Shares of Humana Inc. (NYSE:HUM)

Edgestream Partners L.P. boosted its stake in Humana Inc. (NYSE:HUM - Free Report) by 68.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,826 shares of the insurance provider's stock after acquiring an additional 9,311 shares during the quarter. Edgestream Partners L.P.'s holdings in Humana were worth $6,040,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. CWM LLC lifted its position in Humana by 603.9% in the 1st quarter. CWM LLC now owns 20,919 shares of the insurance provider's stock valued at $5,535,000 after acquiring an additional 17,947 shares in the last quarter. New York State Common Retirement Fund lifted its position in Humana by 4.2% in the 1st quarter. New York State Common Retirement Fund now owns 77,282 shares of the insurance provider's stock valued at $20,449,000 after acquiring an additional 3,100 shares in the last quarter. Arizona State Retirement System lifted its position in Humana by 3.4% in the 1st quarter. Arizona State Retirement System now owns 35,337 shares of the insurance provider's stock valued at $9,350,000 after acquiring an additional 1,165 shares in the last quarter. Xponance Inc. lifted its position in Humana by 20.1% in the 1st quarter. Xponance Inc. now owns 21,200 shares of the insurance provider's stock valued at $5,610,000 after acquiring an additional 3,551 shares in the last quarter. Finally, Cerity Partners LLC lifted its position in Humana by 26.0% in the 1st quarter. Cerity Partners LLC now owns 39,331 shares of the insurance provider's stock valued at $10,407,000 after acquiring an additional 8,119 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

HUM traded down $2.88 on Thursday, reaching $223.68. The company had a trading volume of 1,775,521 shares, compared to its average volume of 1,812,261. The company's fifty day moving average is $236.05 and its 200 day moving average is $257.67. Humana Inc. has a fifty-two week low of $212.45 and a fifty-two week high of $406.46. The stock has a market cap of $27.00 billion, a P/E ratio of 15.82, a P/E/G ratio of 1.52 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same quarter in the prior year, the business posted $7.23 EPS. The business's revenue was up 8.4% compared to the same quarter last year. As a group, analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target on the stock in a research report on Thursday, May 1st. Guggenheim assumed coverage on shares of Humana in a research report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target on the stock. Oppenheimer boosted their price target on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 price target on shares of Humana in a research report on Thursday, May 1st. Finally, Robert W. Baird boosted their price target on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Seventeen research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $279.81.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.